The amount of outstanding funds that the entity is obligated to repay.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Note Expiry date 2027-01-01
-Name IAS
-Number 1
-IssueDate 2025-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_Borrowings
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The exercise price of share options granted.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2025-01-01
-Paragraph 47
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_ExercisePriceShareOptionsGranted2019
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Note Expiry date 2027-01-01
-Name IAS
-Number 1
-IssueDate 2025-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_112_c&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_NotionalAmount
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of (units of) instruments that are antidilutive in the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2025-01-01
-Paragraph 70
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_c&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	duration

- Definition

Threshold period of specified consecutive trading days within which common stock price must exceed threshold percentage for specified number of trading days to trigger vesting feature.

+ References

No definition available.

+ Details

Name:	shmd_EarnoutSharesToBeVestedThresholdConsecutiveTradingDays
Namespace Prefix:	shmd_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Threshold number of specified trading days that common stock price must exceed threshold percentage within a specified consecutive trading period to trigger vesting feature.

+ References

No definition available.

+ Details

Name:	shmd_EarnoutSharesToBeVestedThresholdTradingDays
Namespace Prefix:	shmd_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

No definition available.

+ Details

Name:	shmd_IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
Namespace Prefix:	shmd_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Price of a single share of a number of saleable stocks of a company.

+ References

No definition available.

+ Details

Name:	shmd_IfrsSharePrice
Namespace Prefix:	shmd_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Represents the number of shares issuable under earnout agreement.

+ References

No definition available.

+ Details

Name:	shmd_SharesIssuableUnderEarnoutAgreement
Namespace Prefix:	shmd_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	ifrs-full_BorrowingsByNameAxis=shmd_TwentyTwentyEightConvertibleNotesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_BorrowingsByNameAxis=shmd_TwentyTwentyFiveConvertibleNotesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfAntidilutiveInstrumentsAxis=shmd_EarnoutSharesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=shmd_EarnoutSharesShallVestIfOccurrenceOfSharePriceBeingGreaterThan15.00PerShareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=shmd_EarnoutSharesShallVestIfOccurrenceOfSharePriceBeingGreaterThan18.00PerShareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfAntidilutiveInstrumentsAxis=shmd_TwentyTwentyEightConvertibleNotesWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfAntidilutiveInstrumentsAxis=shmd_TwentyTwentyFiveOptionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfAntidilutiveInstrumentsAxis=shmd_PublicAndPrivateWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

EARNINGS PER SHARE - Potential ordinary shares were excluded from diluted EPS (Details) $ / shares in Units, € in Millions, $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2026 USD ($) shares D $ / shares	Dec. 31, 2025 D $ / shares shares	Jun. 30, 2026 EUR (€) shares	Mar. 31, 2026 USD ($)	Jan. 31, 2026 USD ($)
2028 Convertible Notes
Antidilutive shares not included in the calculation of diluted earnings per share
Principal amount \| $				$ 30.0	$ 30.0
Principal amount remained outstanding \| $	$ 12.0
2025 Convertible Loan
Antidilutive shares not included in the calculation of diluted earnings per share
Principal amount \| €			€ 2.5
Earn-out shares
Antidilutive shares not included in the calculation of diluted earnings per share
Shares issuable under earnout agreement	5,000,000	5,000,000	5,000,000
Earn-out shares \| Earnout shares shall vest if occurrence of share price being greater than 15.00 per share
Antidilutive shares not included in the calculation of diluted earnings per share
Shares issuable under earnout agreement	2,500,000	2,500,000	2,500,000
Share price \| $ / shares	$ 15	$ 15
Threshold number of specified trading days that common stock price \| D	20	20
Threshold period of specified consecutive trading days \| D	30	30
Earn-out shares \| Earnout shares shall vest if occurrence of share price being greater than 15.00 per share
Antidilutive shares not included in the calculation of diluted earnings per share
Shares issuable under earnout agreement	2,500,000		2,500,000
Share price \| $ / shares	$ 18	$ 18
Threshold number of specified trading days that common stock price \| D	20	20
Threshold period of specified consecutive trading days \| D	30	30
2028 Convertible Notes Warrants
Antidilutive shares not included in the calculation of diluted earnings per share
Potential ordinary shares excluded from diluted EPS	3,744,150
Exercise price of warrants \| $ / shares	$ 8.0125
2025 Options
Antidilutive shares not included in the calculation of diluted earnings per share
Potential ordinary shares excluded from diluted EPS	1,250,000
Exercise price of options \| $ / shares	$ 4.1956
Public and private warrants
Antidilutive shares not included in the calculation of diluted earnings per share
Potential ordinary shares excluded from diluted EPS	21,000,000